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Abstract:
Tolterodine, an important urological drug, can be conveniently
prepared starting from 1-[2-hydroxy-5-methyl)phenyl]-1-
phenylethylene, accessible in high yield by alumina-promoted
ortho alkenylation of p-cresol with phenylacetylene. The hy-
droformylation of this olefin, catalyzed by rhodium complexes
both in homogeneous or in aqueous biphasic system, affords
the desired linear aldehyde in about 80-90% yield. The
reductive amination of this aldehyde, in the presence of HN-
(iPr)2 and Pd/C (5%) as the catalytic precursor at 4 atm H2
and 48 °C, produces directly tolterodine in more than 90%
yield. Some experiments of enantioselective hydroformylation
of 1-[2-hydroxy-5-methyl)phenyl]-1-phenylethylene catalyzed by
Rh(CO)2acac/(S,R)-Binaphos and other enantiopure ferrocen-
yldiphosphines afforded only low yields of the expected chiral
aldehyde; unfortunately, the achieved ee did not exceed 8%.
Introduction
Urinary incontinence is a condition affecting more than
10% of the adult population and can represent an embarass-
ing problem for many people, negatively influencing their
normal way of life.1 As the mean age of the worldwide
population begins to rise, one can speculate that such a
pathology is fated to increase its relevance as a health
problem.
In the search for new drugs with improved side effect
profiles to treat an overactive bladder, a family of phenyl-
propylamines as muscarinic receptor antagonists has been
investigated, and very recently, (+)(R)-tolterodine 1 (Figure
1) (brand names Detrol or Detrusitol) was launched and
marketed worldwide with success as the (R,R)-tartaric acid
salt.1,2 The annual consumption increment is estimated about
20%. The bulk production in 15 most industrialized countries
in the world in 1999 was 450 kg.3
The original synthetic approaches to this molecule4 are
characterized by numerous steps (more than six), some of
which involve the use of toxic or hazardous reagents and
solvents, give only fair yields, or both. A classical resolution
via the formation of diastereomeric salts with (R,R)-tartaric
acid is used to achieve the enantiomerically pure molecule;
even if the racemization and the recycle of the unwanted
(S)-enantiomer does not seem particularly difficult to ac-
complish, it requires additional costs; hence, it is strongly
desirable to eliminate it from the productive process. Also,
a recently published asymmetric approach5 to 1 appears quite
costly for industrial application.
Recently, a more efficient synthesis involving a lower step
number has been claimed in a U.S. patent to obtain (R,S)-
tolterodine; this is characterized by the preparation of the
hemiacetalic compound 3,6-dihydro-6-methyl-4-phenyl-2H-
benzopyran-2-ol (3a) as a key intermediate.6
Another more recent patent7 reported a multistep synthetic
route to 3a enriched in the (R)-enantiomer. This fact
documents the remarkable interest in finding asymmetric
processes leading to (+)(R)-tolterodine suitable for industrial
application.
Before these patents were published, we presented at
international symposia8-10 a synthetic approach to hemiacetal
3a following a quite different strategy, namely the regio-
selective rhodium-carbonyl complex-catalyzed hydroform-
ylation of 1-[(2-hydroxy-5-methyl)]-1-phenylethene (2a). We
based this approach on previous experiences11-14 in the
production of several compounds endowed with interesting
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therapeutic activity and containing a 3,3-diarylpropyl- or a
4,4-diarylbutylamine moiety. The idea was to use a synthetic
scheme involving catalytic processes with high atom utiliza-
tion and low salt waste. Indeed, the synthetic route outlined
in the patent6 is afflicted by a serious drawback, namely the
use of DIBAL as the reduction agent, which works in
stoichiometric amount with respect to the lactone at low
temperature; in addition, it is sensitive to air and moisture.
Furthermore, our synthetic approach, involving the hy-
droformylation process could be developed in an enantio-
selective way to produce the key intermediate, hemiacetal
3a, enriched in the desired diastereomer.
Results and Discussion
The synthetic route to (R,S)-tolterodine proposed by us
is depicted in Scheme 1.
This short route not only could offer better overall yields
and significant improvement in terms of cost reduction, but
could also, in principle, permit the formation of a nonracemic
chiral center by using rhodium complexes modified with
enantiomerically pure ligands as catalysts in the hydroform-
ylation step.
The olefinic substrate 2a to be subjected to the oxo
reaction was prepared by ortho alkenylation of p-cresol with
phenylacetylene, both easily available in the industrial
market, according to an experimental procedure described
by Sartori et al.15 and suitably modified by us. In fact, while
the zeolite catalysts employed by these authors, in our hands,
did not give the expected selectivity, much better results were
obtained using acidic Al2O3 activated by calcination at 500
°C for 5 h; almost complete chemoselectivity and yields up
to 90% were achieved. Even if the alumina was used in a
large amount (47 wt % with respect to p-cresol), this does
not represent a serious drawback, owing to its low cost and
the possibility to recover and to reactivate it.
The hydroformylation of olefin 2a to the corresponding
linear aldehyde, mostly in the hemiacetalic form 3a, is
conveniently carried out either in the biphasic water/toluene
system or in organic solvent as, for instance, toluene, in the
presence of an appropriate catalytic precursor (see Table 1).
The results obtained in the aqueous biphasic hydroform-
ylation are particularly attractive in the perspective of a semi-
industrial application due to the use of an environmentally
benign solvent and to the easy separation of the products
and nearly quantitative recovery of the expensive rhodium
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1; Wiley-VCH: Weinheim, 1998; pp 25-48.
(13) Botteghi, C.; Paganelli, S.; Marchetti, M.; Pannocchia, P. J. Mol. Catal. A:
Chem. 1999, 143, 233.
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catalyst; as a matter of fact, we observed, after five recycles
of the catalytic solution, a very small efficiency loss (<5%).
Generally, the only byproduct is compound 4a derived from
the olefinic double bond hydrogenation; sometimes we
noticed that this compound was the main product when
commercial catalytic precursors such as HRh(CO)(PPh3)3 and
[Rh(COD)Cl]2 were employed. When these rhodium com-
plexes are carefully prepared and purified according to well-
known procedures,16,17 the chemoselectivity of the oxo
reaction is fairly good.
The data reported in Table 1 also show the effect of the
phosphine ligands on the reaction; contrary to the results
usually observed in the hydroformylation catalyzed by
rhodium/phospine complexes,18 in several cases we noticed
a detrimental influence of the ligand on both reaction rate
and chemoselectivity (entries 2, 4-8); when this catalytic
process was carried out in the more economically convenient
and environmentally friendly aqueous biphasic system
catalyzed by [Rh(COD)Cl]2/TPPTS, we obtained a good
reaction rate and an almost quantitative chemoselectivity
(entries 9 and 10).19 When Xantphos(SO3Na)2 was used as
the hydrosoluble ligand, both the reaction rate and the
chemoselectivity of the process remarkably decreased (entry
11; see also Figure 2).
Some experiments to prepare (R,S)-tolterodine by reduc-
tive amination of the hemiacetal 3a in the presence of PtO2
as the catalyst and diisopropylamine at 76 atm of H2 and
120 °C for 24 h, following a well-described procedure20 that
demonstrated good success in our previous works,11,12 gave
unsatisfactory results in this case. However, the catalytic
reduction of the corresponding enamine 6, prepared by
treatment with diisopropylamine in the presence of molecular
sieves, afforded the target compound in an efficient way:
83% yield of tolterodine was obtained after 24 h at 120 °C
and 80 atm H2 using PtO2 as the catalyst.20
Finally, following the experimental procedure recently
described in a patent,6 (R,S)-tolterodine was obtained by
reductive amination of 3a after 10 h at 4 atm H2 and 48 °C
in methanol, in the presence of Pd/C (5%): the yield reached
96%. This latter method is strongly preferable because of
the lower cost of the catalyst, the remarkably milder reaction
conditions, and the higher chemical yield obtained.
As only the (+)-(R)-enantiomer of tolterodine displays
the desired pharmacological activity, we devised a way to
prepare this chiral drug by enantioselective hydroformylation
of olefin 2a and subsequent transformation of the enatio-
merically enriched oxo-aldehyde obtained. Indeed, the results
obtained in the hydroformylation of this substrate catalyzed
by rhodium carbonyl complexes modified with phosphorus
external ligand did not appear very promising (see Table 1);
however, we hoped that a high enantioselectivity could
counterbalance a low chemical yield. The catalyst of choice
to perform the oxo process was the system Rh(CO)2acac/
(S,R)-Binaphos (1:4 molar ratio), thus far the most active
catalyst in the enantioselective hydroformylation of various
alkenes.21 This reaction, carried out on substrate 2a in toluene
at 60 °C and 80 atm (CO/H2 ) 1) and with a substrate-to-
rhodium molar ratio of 250 to 1, gave compound 4a as the
only reaction product.
Therefore, we thought to study the behavior towards
hydroformylation of substrate 2b, in which the hydroxy group
was protected as acetoxy derivative, in the aim of improving
the yield of the desired oxo-aldehyde when the oxo process
was catalyzed by rhodium-carbonyl complexes modified
with external phosphorus ligands.
Compound 2b was conveniently prepared in 90% yield
by reacting olefin 2a with acetyl chloride in wet toluene for
2 h at room temperature in the presence of NaOH and the
phase-transfer catalyst tetrabutylammonium hydrogensul-
fate.22
When 2b was used, the reaction catalyzed by Rh-
(CO)2acac/(S,R)-Binaphos21,23 ran again very sluggishly, and
no more than 51% of conversion was achieved after 168 h
at 60 °C and 80 atm (Table 2, entry 1). The chemoselectivity
was also very disappointing, about 27% of olefin hydrogena-
tion product 4b being detected in the reaction mixture. The
chiral nonracemic aldehyde obtained showed an enantiomeric
excess of only 8%. This value was determined by aldehyde(16) Ahmad, N.; Levison, J. J.; Robinson, S. D.; Uttley, M. F. Inorg. Synth.1974, 15, 45.
(17) Chatt, J.; Venanzi, L. M. J. Chem. Soc. 1957, 4735.
(18) Botteghi, C.; Ganzerla, R.; Lenarda, M.; Moretti, G. J. Mol. Catal. 1987,
40, 129 and references therein.
(19) Paganelli, S.; Zanchet, M.; Marchetti, M.; Mangano, G. J. Mol. Catal. A:
Chem. 2000, 157, 1 and references therein.
(20) Jachimowicz, F.; Raksi, J. J. Org. Chem. 1982, 47, 445.
(21) Nozaki, K.; Matsuo, T.; Shibahara, F.; Hiyama, T. AdV. Synth. Catal. 2001,
1, 343.
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Table 1. Rhodium-catalyzed hydroformylation of olefin 2aa









1c [Rh(COD)Cl]2 72 96.0 94.4 1.6
2c,d HRh(CO)(PPh3)3 48 32.3 27.1 5.4
3c HRh(CO)(PPh3)3 48 95.2 91.6 3.6
4c Rh(CO)2acac/PPh3 72 51.3 42.6 8.7
5c Rh(CO)2acac/DPPB 72 83.0 74.5 8.5
6c Rh(CO)2acac/Xantphos 24 10.3 6.0 4.3
7c Rh(CO)2acac/Xantphos 72 90.3 83.5 6.8
8c,e Rh(CO)2acac/Xantphos 72 26.2 7.9 18.3
9f [Rh(COD)Cl]2/TPPTS 48 99.1 99.1 -
10f [Rh(COD)Cl]2/TPPTS 24 80.0 80.0 -
11f [Rh(COD)Cl]2/Xantphos (SO3Na)2g 24 37.7 33.9 3.8
a Experimental conditions: P ) 100 atm (CO/H2 ) 1); temp. ) 100 °C;
substrate/Rh (molar ratio) ) 250/1; ligand/Rh (molar ratio) ) 1.1/1; water soluble
ligand /Rh (molar ratio) ) 3/1; DPPB ) 1,4-bis(diphenylphosphino)butane;
TPPTS ) triphenylphosphine-3,3′,3′′-trisulfonic acid trisodium salt; Xantphos-
(SO3Na)2 ) 2,7-bis(SO3Na)Xantphos. b Determined by GC. c Solvent ) toluene.
d Experiment carried out at 80 °C. e Ligand/Rh (molar ratio) ) 2.2/1. f Solvent
) H2O/toluene. g Catalyst preformed in water at 20 atm (CO/H2 ) 1) and 100
°C for 4 h.
Figure 2.
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3b oxidation to the corresponding acid24 5b and enantiose-
lective HPLC using the chiral column Chiracel OD (Scheme
2).
Since enantiopure ferrocenylphosphines were seldomly
employed as ligands in enantioselective hydroformylation,25,26
we carried out some oxo experiments on olefin 2b using the
diphosphines L1-L3 depicted in Figure 3 to modify the
carbonyl complex Rh(CO)2acac (Table 2). Only in one case
(Table 2, entry 2) we obtained a sufficently high yield (about
62%) to isolate from the reaction mixture and to purify the
aldehyde 3b; this showed negligible ee.
Conclusions
In conclusion, we were able to carry out an efficient route
to (R,S)-tolterodine with an overall yield up to 60%. This
preparative scheme, in our opinion, could be convenient for
an industrial scale-up; however, all the steps of the prepara-
tive route proposed by us and, in particular, that of the
hydroformylation step, are under investigation in our labora-
tory for further improvements. Unfortunately, the asymmetric
hydroformylation will hardly be successfully employed for
the synthesis of enantiomerically enriched (+)-(R)-toltero-
dine, but other more promising enantioselective catalytic
processes are currently under study by us.
Experimental Section
General Methods. The rhodium complexes HRh(CO)-
(PPh3)316 and [Rh(COD)Cl]217 were prepared following well-
known procedures. Rh(CO)2acac and palladium, 5 wt % on
activated carbon, were purchased from Aldrich. Acid Al2O3
(S, 0.063 mm, Riedel-De Haen AG) was activated by
calcination at 550 °C for 5 h before use. Phenylacetylene
was filtered through a short column of alumina and then
distilled at reduced pressure (bp 75 °C/80 mmHg). Molecular
sieves (Aldrich, 4 Å, 1.6 nm) were heated in vacuo at 250
°C for 24 h. (S,R)-Binaphos was prepared following a
described procedure.27 Merck silica gel 60 (240-400 mesh)
was used for column chromatography. NMR spectra were
measured for solutions in CDCl3 using a Bruker AC 200
spectrometer operating at 200 MHz. Solvents were purified
following well-known procedures.28
1-[(2-Hydroxy-5-methyl)phenyl]-1-phenylethylene (2a).
A mixture of p-cresol (2.16 g, 20 mmol), phenylacetylene
(2.2 mL, 200 mmol) and 1 g (47 wt %) of activated acid
alumina S (0.063 mm) in anhydrous 1,2-dichlorobenzene (12
mL) was heated at reflux for 72 h, after which was cooled
to room temperature. The alumina was filtered off and
washed several times with diisopropyl ether. Removal of the
solvent in vacuo left a crude oil, which was purified by
(24) Dalcanale, E.; Montanari, F. J. Org. Chem. 1986, 51, 567.
(25) Botteghi, C.; Delogu, G.; Marchetti, M.; Paganelli, S.; Sechi, B. J. Mol.
Catal. A: Chem. 1999, 143, 311.
(26) Rampf, F. A.; Herrmann, W. A. J. Organomet. Chem. 2000, 601, 138.
(27) Sakai, N.; Mano, S.; Nozaki, K.; Takaia, H. J. Am. Chem. Soc. 1993, 115,
7033.
(28) Perrin, D.; Armarego, L. F. Purification of Laboratory Chemicals, 3rd ed.;
Pergamon Press: Oxford, 1988.
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Table 2. Enantioselective rhodium-catalyzed














1d Binaphos 250/1 168 51.4 24.7 26.7 8
2 L1 307/1 216 >99 61.9 25.5 1
3 L1 250/1 216 >99 37.6 59.0 -
4 L2 250/1 216 66.2 22.0 44.2 -
5 L3 250/1 144 58.7 17.6 41.1 -
a Experimental conditions: cat. ) Rh(CO)2acac; ligand/Rh ) 4/1 (molar ratio);
P ) 100 atm (CO/H2 ) 1); Temp ) 100 °C; solvent ) toluene. b Determined
by GC. b Determined by HPLC (see Experimental Section). c Experiments carried
out at 80 atm (CO/H2 ) 1) and 60 °C.
Figure 3.
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distillation at reduced pressure (81 °C/32 mmHg), so
furnishing olefin 2a as a colorless oil (3.8 g, 90% yield). 1H
NMR ä 7.41-6.85 (m, 8H), 5.88-5.86 (d, J ) 1.21 Hz,
1H), 5.44-5.42 (d, J ) 1.21 Hz, 1H), 5.02 (s, 1H), 2.31 (s,
3H). MS: m/e 210 (M+, 57), 209 (100), 195 (39), 165 (21),
77 (12). Anal. Calcd for C15H14O: C, 85.68; H, 6.71.
Found: C, 85.42; H, 6.68.
1-[(2-Acetoxy-5-methyl)phenyl]-1-phenylethylene (2b).
This olefin was prepared in 90% yield, starting from olefin
2a, according to a described procedure.22 Bp 175 °C/0.1
mmHg. 1H NMR ä 7.45-6.85 (m, 8H), 5.88-5.86 (d, J )
1.21 Hz, 1H), 5.44-5.42 (d, J ) 1.21 Hz, 1H), 2.32 (s, 3H),
1.80 (s, 3H). MS: m/e 252 (M+, 22), 237 (12), 209 (100),
195 (26), 165 (14), 43 (31). Anal. Calcd for C17H16O2: C,
80.93; H, 6.39. Found: C, 80.65; H, 6.37.
Hydroformylation of 2a. A 150-mL stainless steel
reaction vessel was charged under a nitrogen purge with 2
mmol of olefin 2a, 0.008 mmol of rhodium catalyst and 5
mL of anhydrous toluene. The reactor was then pressurized
to 100 atm with syngas (CO/H2 ) 1) and heated at 80-100
°C for 24-72 h (see Table 1). For analytical purposes
aldehyde 3a (hemiacetalic form), a white solid, was recov-
ered from the reaction mixture by flash silica gel chroma-
tography (hexane/ether, 80/20). Mp 82.5 °C. 1H NMR ä
7.40-6.60 (m, 8H), 5.67 (t, J ) 3.05, 1H), 4.36-4.28 (m,
1H), 2.34-2.20 (m, 2H), 2.16 (s, 3H). MS: m/e 240 (M+,
100), 222 (66), 221 (72), 195 (57), 145 (70), 115 (25). Anal.
Calcd for C16H16O2: C, 80.0; H, 6.71. Found: C, 79.76; H,
6.69.
Hydroformylation of 2a in Aqueous Biphase Medium.
In a Schlenk tube [Rh(COD)Cl]2 (4.0 mg, 0.008 mmol) and
TPPTS (27.6 mg, 0.048 mmol) were dissolved under nitrogen
in H2O (2.5 mL); then, a solution of 2a (0.5 g, 2.0 mmol) in
toluene (3 mL) was added. The Schlenk tube containing the
two-phase liquid mixture was transferred to a 150-mL
stainless steel autoclave under nitrogen, pressurized to 100
atm with syngas (CO/H2 ) 1) and heated at 100 °C for 48
h (see Table 1). The reactor was then cooled to room
temperature and the residual gases released. The organic
phase was separated and dried on MgSO4, and toluene was
removed in vacuo; the aldehyde 3a (hemiacetalic form) was
recovered and identified as previously described.
Hydroformylation of 2b. A 150-mL stainless steel
reaction vessel was charged under a nitrogen purge with 2
mmol of olefin 2b, 0.008 mmol of rhodium catalyst, 0.0032
mmol of an external ligand, and 5 mL of anhydrous toluene.
The reactor was then pressurized to 100 atm with syngas
(CO/H2 ) 1) and heated at 80-100 °C for 24-72 h (see
Table 2). For analytical purposes aldehyde 3b, a pale yellow
oil, was recovered from the reaction mixture by flash silica
gel chromatography (hexane/ether, 80/20). 1H NMR ä 9.73
(t, J ) 1.83, 1H), 7.45-6.71 (m, 8H), 4.8-4.68 (t, J ) 7.32,
1H), 3.26-3.0 (m, 2H), 2.35 (s, 3H), 1.81 (s, 3H). MS: m/e
282 (M+, 6), 240 (15), 222 (100), 196 (10), 145 (19). Anal.
Calcd for C18H18O3: C, 76.57; H, 6.42. Found: C, 76.37;
H, 6.40.
Determination of the Enantiomeric Excess. The hy-
droformylation reaction mixture of 2b catalyzed by Rh-
(CO)2acac/(S,R)-Binaphos (see Table 2) was oxidized to the
corresponding 3-[(2-acetoxy-5-methy)phenyl]-3-phenylpro-
panoic acid (5b) with NaClO2, H2O2, and NaH2PO4 in CH3-
CN at 10 °C.24 The enantiomeric excess of 5b was
determined by HPLC analysis using a Chiracel OD 250 mm
 4.6 mm column (n-hexane/2-propanol/formic acid ) 90/
10/1, flux 0.5 mL/min, loop 10 íL, wavenumber 254 nm):
ee ) 8%. Compound 5b: 1H NMR ä 9.71 (s, 1H), 7.45-
6.71 (m, 8H), 4.8-4.68 (m, 1H), 3.3-2.98 (m, 2H), 2.35
(s, 3H), 1.80 (s, 3H). MS: m/e 298 (M+, 1), 280 (1), 238
(100), 220 (30), 195 (57), 165 (11), 91 (4), 77 (5). Anal.
Calcd for C18H18O4: C, 72.47; H, 6.08. Found: C, 72.28;
H, 6.06.
(R,S)-Tolterodine (1). In a 150-mL stainless steel reaction
vessel a solution of 3a (1 g, 4.2 mmol) in 5 mL methanol
was slowly added, under a nitrogen purge, to Pd/C (5%) (0.11
g, 1.03 mmol). Anhydrous N,N-diisopropylamine (0.74 mL,
5.3 mmol) was added and the reactor pressurized to 3 atm
with H2. After 16 h at 50 °C the reactor was cooled to room
temperature and the residual gas released. The reaction
mixture was filtered, and solvent and excess HN(iPr)2 were
distilled off in vacuo; the remaining oil was purified by flash
chromatography as described by Andersson at al.5 Concen-
tration in vacuo yielded 1.32 g (96.8% yield) of (R,S)-
tolterodine 1 as a colorless oil. 1H NMR ä 7.35-6.83 (m,
8H), 6.55 (s, 1H), 4.53-4.46 (m, 1H), 3.24 (q, J ) 6.71,
2H), 2.77-2.69 (m, 2H), 2.43-2.32 (m, 2H), 2.13 (s, 3H),
1.14 (d, J ) 6.71, 6H), 1.09 (d, J ) 6.71, 6H). 13C NMR
(300 MHz) ä 153.11 (CHOH), 144.6 (ArCHCH), 132.3-
125.9 (5C, C6H3), 77.45.76.6 (5C, C6H5), 48.2 [N(CHCH3)2],
42.2 (NCH2), 39.5 [(Ar)(Ph)CH], 33.2 (CHCH2CH2), 20.9
(PhCH3), 19.8 [CH(CH3)2], 19.4 [CH(CH3)2]. MS: m/e 325
(M+, 8), 310 (13), 114 (100), 100 (5). Anal. Calcd for C18H18-
NO3: C, 81.18; H, 9.6; N, 4.3. Found: C, 80.94; H,9.56; N,
4.1
(R,S)-Tolterodine (1) by Hydrogenation of Enamine
6. A solution of hemiacetal 3a (0.5 g, 2.08 mmol) and
anhydrous N,N-diisopropylamine (1.05 mL, 7.5 mmol) in 2
mL of anhydrous toluene were slowly stirred, under a
nitrogen purge, at 50 °C in the presence of freshly activated
4 Å molecular sieves (2 g). After 72 h the conversion of 3a
to N,N-diisopropyl-3-[(2-Hydroxy-5-methyl)phenyl]-3-phe-
nylprop-1-enamine (6) was complete; the molecular sieves
were filtered off, and the solvent was evaporated at reduced
pressure. Compound 6 was characterized by GC/MS; MS:
m/e 323 (M+, 50), 308 (5), 280 (7), 126(100), 84 (94), 71
(91), 43 (59).
The enamine 6, recovered from the reaction mixture
without any further purification, was dissolved in anhydrous
toluene (10 mL) and hydrogenated in the presence of PtO2
(5.0 mg, 0.019 mmol) at 120 °C and 80 atm H2 for 24 h.20
Tolterodine was obtained in about 90% yield and character-
ized as described above.
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